Every day on Wall Street, certain stocks trading for under $10 a share don't experience massive spikes higher. Traders savvy enough to follow the low-priced names and trade them with discipline and sod risk management are banking ridiculous coin on a regular basis.

Just take a look at some of the big movers to the upside in the under-$10 complex from Wednesday, including Acasti Pharma (ACST) , which exploded higher by 123%; Biostar Pharmaceuticals (BSPM) , which soared higher by 65.3%; Chanticleer Holdings (HOTR) , which ripped up by 31.1%; and Navidea Biopharmaceuticals (NAVB) , which surged by 20%. You don't even have to catch the entire move in lower-priced stocks such as these to make outsized returns when trading.

Low-priced stocks are something that I tweet about on a regular basis. These are also the exact type of stocks that I love to trade and alert to my subscribers in real-time. I frequently flag high-probability setups, breakout candidates and low-priced stocks that are acting technically bullish. I like to hunt for low-priced stocks that are showing bullish price and volume trends, since that increases the probability of those stocks heading higher. These setups often produce monster moves higher in very short time frames.

When I trade under-$10 stocks, I do it almost entirely based off of the charts and technical analysis. I also like to find under-$10 stocks with a catalyst, but that's secondary to the chart and volume patterns.

With that in mind, here's a look at several under-$10 stocks that look poised to potentially trade higher from current levels.

Collegium Pharmaceutical

One under-$10 specialty pharmaceutical player that's starting to spike within range of triggering a near-term breakout trade is Collegium Pharmaceutical  (COLL) , which develops and commercializes abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases. This stock has been smacked lower by the sellers over the last six months, with shares off sharply by 44.2%.

If you take a glance at the chart for Collegium Pharmaceutical, you'll notice that this stock has been downtrending badly over the last six months, with shares falling sharply lower off its high of $19.99 a share to its new 52-week low of $8.24 a share. During that downtrend, shares of Collegium Pharmaceuticals have been consistently making lower highs and lower lows, which is bearish technical price action. That said, this stock has now started to bounce some off that $8.24 low and it's quickly trending within range of triggering a near-term breakout trade.

Market players should now look for long-biased trades in shares of Collegium Pharmaceutical if it manages to break out above some near-term overhead resistance levels at $10.06 to $10.40 a share and then above more resistance levels $10.55 to $10.75 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 167,947 shares. If that breakout develops soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 50-day moving average of $11.22 to $11.73, or even $12.50 to $13 a share.

Traders can look to buy this stock off weakness to anticipate that breakout and simply use a stop that sits right below some near-term support levels at $9 to $8.79 a share. One can also buy shares of Collegium Pharmaceutical off strength once it starts to move above those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

ContraVir Pharmaceuticals

Another under-$10 biopharmaceutical player that's starting to trend within range of triggering a big breakout trade is ContraVir Pharmaceuticals  (CTRV) , which is focused on the discovery and development of targeted antiviral therapies. This stock has been destroyed by the sellers over the last six months, with shares plunging lower by 75.1%.

If you take a look at the chart for ContraVir Pharmaceuticals, you'll notice that this stock recently formed a double bottom chart pattern, after shares found some buying interest at 96 to 95 cents per share over the last two months. Following that potential bottom, this stock has now started to spike higher and trend above its 50-day moving average of $1.07 a share with decent upside volume. That move is now quickly pushing shares of ContraVir Pharmaceuticals within range of triggering a big breakout trade above some key overhead resistance levels.

Market players should now look for long-biased trades in ContraVir Pharmaceuticals if it manages to break out above some near-term overhead resistance levels at $1.17 to $1.20 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 167,091 shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance level at $1.40 a share. Any high-volume move above $1.40 a share will then give this stock a chance to re-fill some of its previous gap-down-day zone from March that started near $2 a share.

Traders can look to buy this stock off weakness to anticipate that breakout and simply use a stop that sits right around those recent double bottom support levels. One can also buy shares of ContraVir Pharmaceuticals off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Adaptimmune Therapeutics

Another under-$10 clinical-stage biopharmaceutical player that's starting to trend within range of triggering a big breakout trade is Adaptimmune Therapeutics  (ADAP) , which focuses on the provision of cancer immunotherapy products based on its T-cell receptor platform. This stock has been under notable selling pressure over the last three months, with shares moving lower by 18.1%.

If you take a glance at the chart for Adaptimmune Therapeutics, you'll notice that this stock has been downtrending badly over the last three months and change, with shares sliding lower off its high of $11.58 a share to its recent low of $6.41 a share. During that downtrend, this stock has been making mostly lower highs and lower lows, which is bearish technical price action. That said, this stock has recently started to reverse that downtrend a bit and it's quickly trending within range of triggering a big breakout trade above some key overhead resistance levels.

Traders should now look for long-biased trades in Adaptimmune Therapeutics if it manages to break out above some near-term overhead resistance levels at its 50-day moving average of $7.68 a share and then above more key resistance levels at $7.78 to $8.15 a share with volume that hits near or above its three-month average action of 124,483 shares. If that breakout develops soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 200-day moving average of $8.68 a share to $8.89, or even $9.50 to $10 a share.

Traders can look to buy this stock off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support at $6.99 a share. One can also buy shares of Adaptimmune Therapeutics off strength once it starts to move above those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Papa Murphy's

An under-$10 specialty eateries player that's starting to rip within range of triggering a big breakout trade is Papa Murphy's  (FRSH) , which together with its subsidiaries, owns, operates and franchises Take N Bake pizza stores. This stock has been under heavy selling pressure over the last six months, with shares dropping large by 42.6%.

If you look at the chart for Papa Murphy's, you'll notice that this stock recently formed a double bottom chart pattern, after shares found some buying interest at $5.72 to $5.74 a share over the last two months. This stock has now started to trend a bit higher off those double bottom support levels, and it's started to move back above its 20-day moving average of $5.94 a share. That bump to the upside is now quickly pushing shares of Papa Murphy's within range of triggering a big breakout trade above some key overhead resistance levels.

Market players should now look for long-biased trades in Papa Murphy's if it manages to break out above some near-term overhead resistance levels at $6.10 to $6.24 a share and then above its 50-day moving average of $6.41 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 220,280 shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $7.25 to $7.50, or even $7.80 to $8.33 a share.

Traders can look to buy Papa Murphy's off weakness to anticipate that breakout and simply use a stop that sits right around those recent double bottom support levels. One can also buy this stock off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Everyday Health

One final under-$10 health care information services player that's starting to trend within range of triggering a big breakout trade is Everyday Health  (EVDY) , which operates digital marketing and communications platform for health care marketers primarily in the U.S. This stock has been in play with the bulls over the last six months, with shares ripping sharply higher by 37.8%.

If you take a glance at the chart for Everyday Health, you'll notice that this stock recently formed a double bottom chart pattern, after shares found some buying interest at $7.02 to $7.01 a share over the last three months. Following that potential bottom, this stock has now started to spike higher and move back above its 20-day moving average of $7.44 a share. That bump to the upside is now quickly pushing shares of Everyday Health within range of triggering a big breakout trade above some key overhead resistance levels.

Traders should now look for long-biased trades in Everyday Health if it manages to break out above some near-term overhead resistance levels at $7.60 to $7.72 a share and then above its 50-day moving average of $7.84 a share to more resistance at $8 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 163,548 shares. If that breakout develops soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $8.40 to $8.71 a share. Any high-volume move above $8.71 a share will then give this stock a chance to re-fill some of its previous gap-down-day zone from last November that started at $10.60 a share.

Traders can look to buy shares of Everyday Health off weakness to anticipate that breakout and simply use a stop that sits right around those recent double bottom support levels. One can also buy this stock off strength once it starts to bust above those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

This article is commentary by an independent contributor. At the time of publication, the author held no positions in the stocks mentioned.

More from Stocks

This Market is Treacherous: Cramer's 'Mad Money' Recap (Thursday 12/11/18)

This Market is Treacherous: Cramer's 'Mad Money' Recap (Thursday 12/11/18)

Real Money Video Wrap: Volatility Reigns

Real Money Video Wrap: Volatility Reigns

Nvidia Shares Fall as SoftBank Reportedly Plans to Sell Its Stake

Nvidia Shares Fall as SoftBank Reportedly Plans to Sell Its Stake

Chart of the Day: McDonald's Management Maneuvers Amid Taxes, Tariffs

Chart of the Day: McDonald's Management Maneuvers Amid Taxes, Tariffs

Stocks End Mixed as China Trade Progress Offsets D.C. Dysfunction

Stocks End Mixed as China Trade Progress Offsets D.C. Dysfunction